Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

<p>Supplementary Figure 6: Overall Survival according to PTEN mutation status in the group of IDH-wildtype glioblastomas (n = 362).</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Tobias Kessler (17079209) (author)
Andere auteurs:	Daniel Schrimpf (17079212) (author), Laura Doerner (17079215) (author), Ling Hai (17079218) (author), Leon D. Kaulen (17079221) (author), Jakob Ito (17079224) (author), Martin van den Bent (17079227) (author), Martin Taphoorn (17079230) (author), Alba A. Brandes (17079233) (author), Ahmed Idbaih (17079236) (author), Julien Dômont (17079239) (author), Paul M. Clement (15044256) (author), Mario Campone (15027156) (author), Martin Bendszus (17079242) (author), Andreas von Deimling (15037904) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Wolfgang Wick (15018168) (author), Antje Wick (17079245) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

_version_	1849927632750116864
author	Tobias Kessler (17079209)
author2	Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
author2_role	author author author author author author author author author author author author author author author author author author
author_facet	Tobias Kessler (17079209) Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
author_role	author
dc.creator.none.fl_str_mv	Tobias Kessler (17079209) Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
dc.date.none.fl_str_mv	2025-11-25T13:22:32Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30708529
dc.relation.none.fl_str_mv	https://figshare.com/articles/figure/Supplementary_Figure_S6_from_Prognostic_Markers_of_DNA_Methylation_and_Next-Generation_Sequencing_in_Progressive_Glioblastoma_from_the_EORTC-26101_Trial/30708529
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
dc.title.none.fl_str_mv	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
dc.type.none.fl_str_mv	Image Figure info:eu-repo/semantics/publishedVersion image
description	<p>Supplementary Figure 6: Overall Survival according to PTEN mutation status in the group of IDH-wildtype glioblastomas (n = 362).</p>
eu_rights_str_mv	openAccess
id	Manara_ee50cf78add181ba461ad81a822ac86d
identifier_str_mv	10.1158/1078-0432.30708529
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30708529
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Kessler (17079209)Daniel Schrimpf (17079212)Laura Doerner (17079215)Ling Hai (17079218)Leon D. Kaulen (17079221)Jakob Ito (17079224)Martin van den Bent (17079227)Martin Taphoorn (17079230)Alba A. Brandes (17079233)Ahmed Idbaih (17079236)Julien Dômont (17079239)Paul M. Clement (15044256)Mario Campone (15027156)Martin Bendszus (17079242)Andreas von Deimling (15037904)Felix Sahm (15097382)Michael Platten (15018165)Wolfgang Wick (15018168)Antje Wick (17079245)CancerCancer Detection and DiagnosisClinical Research and TrialsMethods and TechnologyBiomarkersEpigenetic biomarkersPrognostic biomarkersCNS CancersGliomas, GlioblastomasComputational MethodsSequence analysisPrecision Medicine<p>Supplementary Figure 6: Overall Survival according to PTEN mutation status in the group of IDH-wildtype glioblastomas (n = 362).</p>2025-11-25T13:22:32ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30708529https://figshare.com/articles/figure/Supplementary_Figure_S6_from_Prognostic_Markers_of_DNA_Methylation_and_Next-Generation_Sequencing_in_Progressive_Glioblastoma_from_the_EORTC-26101_Trial/30708529CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307085292025-11-25T13:22:32Z
spellingShingle	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial Tobias Kessler (17079209) Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
status_str	publishedVersion
title	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_full	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_fullStr	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_full_unstemmed	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_short	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_sort	Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
topic	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine

Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

Gelijkaardige items